Cas no 861446-23-3 (1-O-Levulinoyl Resveratrol Diacetate)
1-O-Levulinoyl Resveratrol Diacetate Chemical and Physical Properties
Names and Identifiers
-
- 1-O-Levulinoyl Resveratrol Diacetate
- 3,4'-Diacetoxy-5-(levulinoyloxy)stilbene
- [3-Acetyloxy-5-[(E)-2-(4-acetyloxyphenyl)ethenyl]phenyl] 4-oxopentanoate
-
- Inchi: 1S/C23H22O7/c1-15(24)4-11-23(27)30-22-13-19(12-21(14-22)29-17(3)26)6-5-18-7-9-20(10-8-18)28-16(2)25/h5-10,12-14H,4,11H2,1-3H3/b6-5+
- InChI Key: MNLPGXAHAQDWEJ-AATRIKPKSA-N
- SMILES: O(C(CCC(C)=O)=O)C1C=C(C=C(/C=C/C2C=CC(=CC=2)OC(C)=O)C=1)OC(C)=O
Computed Properties
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 7
- Heavy Atom Count: 30
- Rotatable Bond Count: 11
- Complexity: 646
- Topological Polar Surface Area: 96
1-O-Levulinoyl Resveratrol Diacetate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | L379700-10mg |
1-O-Levulinoyl Resveratrol Diacetate |
861446-23-3 | 10mg |
$ 150.00 | 2023-09-07 | ||
| TRC | L379700-100mg |
1-O-Levulinoyl Resveratrol Diacetate |
861446-23-3 | 100mg |
$ 1183.00 | 2023-09-07 | ||
| Biosynth | LJB44623-5 mg |
1-o-Levulinoyl resveratrol diacetate |
861446-23-3 | 5mg |
$105.00 | 2023-01-04 | ||
| Biosynth | LJB44623-10 mg |
1-o-Levulinoyl resveratrol diacetate |
861446-23-3 | 10mg |
$168.00 | 2023-01-04 | ||
| Biosynth | LJB44623-25 mg |
1-o-Levulinoyl resveratrol diacetate |
861446-23-3 | 25mg |
$315.00 | 2023-01-04 | ||
| Biosynth | LJB44623-50 mg |
1-o-Levulinoyl resveratrol diacetate |
861446-23-3 | 50mg |
$504.00 | 2023-01-04 | ||
| Biosynth | LJB44623-100 mg |
1-o-Levulinoyl resveratrol diacetate |
861446-23-3 | 100MG |
$806.00 | 2023-01-04 |
1-O-Levulinoyl Resveratrol Diacetate Related Literature
-
Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
-
Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
-
Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
-
Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
Additional information on 1-O-Levulinoyl Resveratrol Diacetate
1-O-Levulinoyl Resveratrol Diacetate: A Comprehensive Overview
The compound with CAS No 861446-23-3, known as 1-O-Levulinoyl Resveratrol Diacetate, has garnered significant attention in the scientific community due to its unique chemical structure and potential bioactive properties. This compound is a derivative of resveratrol, a well-known polyphenol with extensive research focusing on its antioxidant, anti-inflammatory, and anticancer activities. The addition of levulinoyl and diacetate groups to the resveratrol backbone introduces novel functional properties, making 1-O-Levulinoyl Resveratrol Diacetate a promising candidate for various applications in the fields of nutrition, cosmetics, and pharmaceuticals.
Resveratrol, a naturally occurring stilbene, is primarily found in grapes, berries, and peanuts. Its ability to modulate cellular signaling pathways and interact with key enzymes such as sirtuins has been extensively studied. However, the bioavailability of resveratrol is limited due to its rapid metabolism and poor absorption in the gastrointestinal tract. To overcome these limitations, researchers have explored various derivatization strategies, including esterification. The synthesis of 1-O-Levulinoyl Resveratrol Diacetate involves the esterification of resveratrol with levulinate and acetate groups, which not only enhances its stability but also improves its solubility and bioavailability.
Recent studies have demonstrated that 1-O-Levulinoyl Resveratrol Diacetate exhibits enhanced antioxidant activity compared to native resveratrol. This is attributed to the conjugation effects introduced by the levulinoyl group, which stabilizes the molecule's structure and prevents rapid degradation. Additionally, the diacetate groups may play a role in modulating the compound's interaction with cellular membranes, potentially enhancing its ability to penetrate cell membranes and exert its effects at the molecular level.
The anti-inflammatory properties of 1-O-Levulinoyl Resveratrol Diacetate have also been explored in preclinical models. Inflammation is a critical factor in numerous chronic diseases, including cardiovascular disorders, diabetes, and neurodegenerative conditions. By inhibiting pro-inflammatory cytokines such as TNF-α and IL-6, this compound demonstrates potential as an adjunct therapy for inflammatory diseases. Furthermore, its ability to modulate nuclear factor-kappa B (NF-κB) signaling pathways suggests a broader role in immune regulation.
One of the most exciting areas of research surrounding 1-O-Levulinoyl Resveratrol Diacetate is its potential anticancer activity. Preclinical studies have shown that this compound can induce apoptosis in various cancer cell lines while sparing normal cells. This selective cytotoxicity is likely due to its ability to target key oncogenic pathways such as PI3K/AKT/mTOR and MAPK/ERK. Moreover, the compound has shown synergistic effects when combined with conventional chemotherapy agents, suggesting that it could be used as an adjuvant in cancer treatment regimens.
Another area of interest is the potential of 1-O-Levulinoyl Resveratrol Diacetate in skin care applications. Its strong antioxidant properties make it an ideal candidate for combating oxidative stress-induced skin damage. Studies have shown that this compound can protect against UV-induced photodamage by reducing reactive oxygen species (ROS) levels and preserving collagen integrity. Additionally, its anti-inflammatory properties may help alleviate conditions such as acne and dermatitis.
The synthesis of 1-O-Levulinoyl Resveratrol Diacetate involves a multi-step process that includes isolation of resveratrol from natural sources or chemical synthesis followed by esterification with levulinate and acetate groups. The optimization of reaction conditions such as temperature, pH, and catalyst selection is crucial for achieving high yields and maintaining product purity. Researchers have also explored green chemistry approaches to make the synthesis process more sustainable and environmentally friendly.
In terms of bioavailability enhancement strategies, researchers have investigated various delivery systems for 1-O-Levulinoyl Resveratrol Diacetate, including lipid nanoparticles (LNPs), micelles, and hydrogels. These delivery systems not only improve solubility but also protect the compound from enzymatic degradation during transit through the gastrointestinal tract. Preclinical studies using these delivery systems have shown improved pharmacokinetics profiles compared to free resveratrol.
The global market for resveratrol derivatives is growing rapidly due to increasing consumer awareness of health benefits associated with polyphenols. Companies are investing heavily in research and development to bring novel products based on compounds like 1-O-Levulinoyl Resveratrol Diacetate to market. These products include dietary supplements, functional foods, skincare formulations, and nutraceuticals.
In conclusion,1-O-Levulinoyl Resveratrol Diacetate represents a significant advancement in the field of natural product derivatization. Its enhanced bioavailability, improved stability profile,and potent bioactive properties make it a versatile compound with applications across multiple industries.The ongoing research into its mechanisms of action,potential therapeutic uses,and optimal delivery systems will undoubtedly pave the way for new innovations in health care products.
861446-23-3 (1-O-Levulinoyl Resveratrol Diacetate) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)